Who we are

Located in 25 countries across 5 continents, the Institut Pasteur International Network (“the Network”) brings together 33 members, united by the Pasteurian values and missions for the benefit the world’s populations.

The Network is represented by the Pasteur International Network association (PINa), which was founded in 2011 under the French law of 1901 governing associations.

For the past century, the Network has served as a sentinel for emerging infectious diseases in several endemic regions of the world, leveraging unique multidisciplinary cooperation in the field of health. The Institut Pasteur International Network strives to improve human health by fighting against infectious diseases, through biomedical research, public health activities, training, and innovation.

The 33 Network members, partners and associates in scientific research, public health services, and education alliances, have signed the Institut Pasteur International Network Cooperation Agreement, which incorporates the Charter of Pasteurian Values adopted by all stakeholders. Humanitarianism, universalism, rigor and dedication, freedom of initiative, the spread of knowledge, and free access to information are the core values we aspire to uphold.

Our action is guided by the principles of scientific solidarity in a bid to help address national and international needs and develop the next generation of researchers, health science entrepreneurs and public health specialists to tackle global public health challenges.

Vision

As a unique model of cooperation in the field of health, the Network connects men and women on every continent, contributing daily to gain ground in the fight against infectious agents for a better global health through the following actions:

  • Biomedical Research
  • Public Health Activities
  • Education and Training
  • Business Development and Technology Transfer

These activities also promote sustainable development goals, which include local capacity building with respect for human rights and environment protection. To face the challenges ahead, the association provides for a flexible operational platform that facilitates the development and implementation of large-scale scientific research and training initiatives, generally with the participation of several Network members.

Scientific strategy

The Network is a unique model of collaboration and represents an outstanding base from which to develop international scientific cooperation. The Institut Pasteur International Network adopted an ambitious collective scientific strategy in 2017 to strengthen its position and promote its role as a global player in public health.

Four key scientific priorities were identified, stemming from an in-depth analysis of the particular features and assets of our unique, constantly growing Network.

This strategy will evolve to adapt to new global challenges and its success depends on the pooling of resources and data, and the sharing of knowledge, resources, and cutting-edge technology.

The strategy is assessed and evaluated by different governing bodies, namely the Scientific Advisory Committee and the General Assembly, to ensure transparency.

Tete de moustique femelle Aedes albopictus, vecteur du virus de la dengue et du chikungunya.

Four scientific priorities

1. Exploring the principal endemic and emergent zoonoses according to a one health approach

Studies will target the pathogen, any vectors it may have, humans, and domestic and wild reservoir animals, as they evolve in their various ecosystems, either natural or transformed by humans. Particular interest will be paid to neglected tropical infectious diseases (rabies, leptospirosis, etc.), the study of antimicrobial resistance, and emerging/related infections to map their distribution across different ecosystems.

2. Studying vector-borne infectious disease

With a focus on the biology of vector insects, their genetic diversity, pathogen-vector interactions, the natural history of infection in humans and animals based on individual factors, the dynamics of installation in newly invaded territories, and determining factors. The increasingly limited context of the anti-vector fight justifies the study of innovative vector control strategies.

3. Exploring the risk of infection in the first years of life, particularly in marginalized and migrant populations

During the pre and perinatal periods: studying the maternofoetal transmission of infection. During childhood: studying the impact of malnutrition, respiratory infections, diarrhoea, and encephalitis on neurological and cognitive development and growth. During adolescence: studying the health risks specific to this period of transition.

4. Studying the impact of aging/longevity on health

Chronic diseases such as metabolic syndromes, cancer, genetic diseases, neurodegenerative conditions, inflammatory diseases.

History of the Institut Pasteur

For a historical account of the Institut Pasteur and Louis Pasteur, visit the dedicated web page.